Race to stop TB: can a One-Month pill course beat the standard?
NCT ID NCT05118490
Summary
This study tests two different drug regimens to prevent tuberculosis (TB) in people at high risk. It compares a shorter, daily 1-month treatment to the standard weekly 3-month treatment. The goal is to see if the shorter course is easier for people to complete and just as safe and effective at preventing TB disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fundação Aurum (The Aurum Institute Mozambique)
Chokwé, Gaza Province, Mozambique
-
The Aurum Institute: Gavin J Churchyard Legacy Centre
Klerksdorp, North West, 2571, South Africa
-
The Byramjee Jeejeebhoy Medical Centre (BJGMC-JHU) CRS
Pune, Maharashtra, 411001, India
-
Yayasan KNCV - The Persahabatan Hospital, Jakarta
Jakarta, Jaya, 14350, Indonesia
Conditions
Explore the condition pages connected to this study.